Karen E. King

7.4k total citations · 1 hit paper
111 papers, 5.1k citations indexed

About

Karen E. King is a scholar working on Hematology, Genetics and Transplantation. According to data from OpenAlex, Karen E. King has authored 111 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Hematology, 26 papers in Genetics and 24 papers in Transplantation. Recurrent topics in Karen E. King's work include Blood groups and transfusion (40 papers), Renal Transplantation Outcomes and Treatments (23 papers) and Blood transfusion and management (23 papers). Karen E. King is often cited by papers focused on Blood groups and transfusion (40 papers), Renal Transplantation Outcomes and Treatments (23 papers) and Blood transfusion and management (23 papers). Karen E. King collaborates with scholars based in United States, Canada and United Kingdom. Karen E. King's co-authors include Paul M. Ness, R. Sue Shirey, Aaron A.R. Tobian, Andrea A. Zachary, Daniel Warren, Robert A. Montgomery, Christopher E. Simpkins, Dorry L. Segev, Mark Haas and Edward S. Kraus and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Karen E. King

109 papers receiving 5.0k citations

Hit Papers

Desensitization in HLA-In... 2011 2026 2016 2021 2011 100 200 300 400

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Karen E. King 2.0k 1.7k 1.3k 978 927 111 5.1k
Nancy M. Dunbar 196 0.1× 1.3k 0.8× 606 0.5× 838 0.9× 798 0.9× 101 4.2k
Judith Marsh 389 0.2× 6.6k 3.9× 682 0.5× 2.7k 2.7× 285 0.3× 210 9.1k
Meghan Delaney 111 0.1× 1.8k 1.0× 627 0.5× 632 0.6× 752 0.8× 134 4.3k
Carl E. Haisch 1.3k 0.6× 233 0.1× 1.4k 1.1× 715 0.7× 157 0.2× 101 3.0k
Hildegard Greinix 483 0.2× 5.6k 3.3× 564 0.4× 2.6k 2.6× 112 0.1× 244 8.9k
Gaetano Ciancio 3.0k 1.5× 408 0.2× 3.2k 2.4× 611 0.6× 35 0.0× 363 7.2k
Jörg Halter 357 0.2× 1.6k 1.0× 414 0.3× 624 0.6× 64 0.1× 161 3.5k
Glenn Ramsey 328 0.2× 969 0.6× 626 0.5× 118 0.1× 821 0.9× 79 2.4k
Hans A. Messner 148 0.1× 3.1k 1.8× 445 0.3× 1.2k 1.2× 101 0.1× 221 5.7k
Bronwen E. Shaw 582 0.3× 3.6k 2.1× 285 0.2× 1.7k 1.8× 47 0.1× 225 5.2k

Countries citing papers authored by Karen E. King

Since Specialization
Citations

This map shows the geographic impact of Karen E. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen E. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen E. King more than expected).

Fields of papers citing papers by Karen E. King

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen E. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen E. King. The network helps show where Karen E. King may publish in the future.

Co-authorship network of co-authors of Karen E. King

This figure shows the co-authorship network connecting the top 25 collaborators of Karen E. King. A scholar is included among the top collaborators of Karen E. King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen E. King. Karen E. King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ramsey, Glenn, Yara A. Park, Anne F. Eder, et al.. (2022). Obstetric and Newborn Weak D-Phenotype RBC Testing and Rh Immune Globulin Management Recommendations: Lessons From a Blinded Specimen-Testing Survey of 81 Transfusion Services. Archives of Pathology & Laboratory Medicine. 147(1). 71–78. 6 indexed citations
2.
Goel, Ruchika, Paul M. Ness, Clifford M. Takemoto, et al.. (2015). Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality. Blood. 125(9). 1470–1476. 154 indexed citations
3.
Campian, Jian, Xiaobu Ye, Douglas E. Gladstone, et al.. (2015). Pre-radiation lymphocyte harvesting and post-radiation reinfusion in patients with newly diagnosed high grade gliomas. Journal of Neuro-Oncology. 124(2). 307–316. 36 indexed citations
4.
Goel, Ruchika, Paul M. Ness, Clifford M. Takemoto, Karen E. King, & Aaron A.R. Tobian. (2014). Risk-Predictors of Mortality in Hospitalized Patients with Thrombotic Thrombocytopenic Purpura: Nationally Representative Data from 2007-2011. Blood. 124(21). 4290–4290. 1 indexed citations
5.
Tobian, Aaron A.R., Alice K. Fuller, Daniel J. Tisch, et al.. (2013). The impact of platelet additive solution apheresis platelets on allergic transfusion reactions and corrected count increment (CME). Transfusion. 54(6). 1523–1529. 71 indexed citations
6.
Khan, Arifa S., A. S. Lubiniecki, & Karen E. King. (2012). PDA/FDA Adventitious Agents and Novel Cell Substrates: Emerging Technologies and New Challenges, Nov. 3-4, 2011, Rockville, MD. PDA Journal of Pharmaceutical Science and Technology. 66(6). 502–511. 7 indexed citations
7.
Louissaint, Nicolette A., Sridhar Nimmagadda, Edward J. Fuchs, et al.. (2011). Distribution of Cell-Free and Cell-Associated HIV Surrogates in the Colon After Simulated Receptive Anal Intercourse in Men Who Have Sex With Men. JAIDS Journal of Acquired Immune Deficiency Syndromes. 59(1). 10–17. 30 indexed citations
8.
Tobian, Aaron A.R., William Savage, Daniel J. Tisch, et al.. (2011). Prevention of allergic transfusion reactions to platelets and red blood cells through plasma reduction. Transfusion. 51(8). 1676–1683. 121 indexed citations
9.
Zucker, Andrew A. & Karen E. King. (2009). Teaching with Laptops. The Science Teacher. 76(9). 22–26. 5 indexed citations
10.
King, Karen E.. (2009). Blood transfusion therapy : a physician's handbook. 5 indexed citations
12.
Tormey, Christopher A., et al.. (2009). Improved plasma removal efficiency for therapeutic plasma exchange using a new apheresis platform. Transfusion. 50(2). 471–477. 25 indexed citations
13.
Zhan, Huichun, Michael B. Streiff, Karen E. King, & Jodi B Segal. (2009). Thrombotic thrombocytopenic purpura at the Johns Hopkins Hospital from 1992 to 2008: clinical outcomes and risk factors for relapse. Transfusion. 50(4). 868–874. 20 indexed citations
14.
Simpkins, Christopher E., Dorry L. Segev, Daniel Warren, et al.. (2008). Rapid Accomodation of an A1 Renal Allograft after Preconditioning for ABO-Incompatible Transplantation. Contributions to nephrology. 162. 35–46. 11 indexed citations
15.
Segev, Dorry L., Christopher E. Simpkins, Daniel Warren, et al.. (2005). ABO Incompatible High‐Titer Renal Transplantation without Splenectomy or Anti‐CD20 Treatment. American Journal of Transplantation. 5(10). 2570–2575. 117 indexed citations
16.
King, Karen E. & Paul M. Ness. (2005). Treatment of Autoimmune Hemolytic Anemia. Seminars in Hematology. 42(3). 131–136. 63 indexed citations
17.
King, Karen E., Daniel Warren, Milagros Samaniego, et al.. (2004). Antibody, complement and accommodation in ABO-incompatible transplants. Current Opinion in Immunology. 16(5). 545–549. 29 indexed citations
18.
Nowak‐Węgrzyn, Anna, et al.. (2001). Fatal Warm Autoimmune Hemolytic Anemia Resulting From IgM Autoagglutinins in an Infant With Severe Combined Immunodeficiency. ˜The œAmerican journal of pediatric hematology/oncology. 23(4). 250–252. 19 indexed citations
19.
King, Karen E.. (1998). Canonización y marginación: María de Magdala.. Concilium: Revista internacional de teología. 43–53.
20.
King, Karen E. & Paul M. Ness. (1996). TREATING ANEMIA. Hematology/Oncology Clinics of North America. 10(6). 1305–1320. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026